New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2014
09:11 EDTMDCO, RTRX, ANGI, AVP, HOT, DRRX, OWW, ITRI, WFM, MDLZ, CRME, LF, URS, SKX, TWC, CHTR, CMCSA, CSCOOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Skechers (SKX), up 14%... Orbitz (OWW), up 14%... Retrophin (RTRX), up 29%... ION Geophysical (IO), up 27%... Avon Products (AVP), up 3%. ALSO HIGHER: Time Warner Cable (TWC), up 8.6% after agreeing to be acquired by Comcast (CMCSA) in a $45.2B stock swap deal. Comcast class A shares are down about 2% after the deal announcement. Charter (CHTR), which was also vying to buy TWC, are down 9% after Comcast struck its deal... Cardiome (CRME), up 20% after Brinavess shows positive results in cardiological study. DOWN AFTER EARNINGS: Cisco (CSCO), down 3.7%... Mondelez (MDLZ), down 3%... Starwood Hotels (HOT), down 2.3%... URS Corporation (URS), down 15%... Itron (ITRI), down 22%... Angie's List (ANGI), down 19%... LeapFrog (LF), down 10%... Cabelas (CAB), down 9%... Whole Foods (WFM), down 7%... NetApp (NTAP), down 4.5%. ALSO LOWER: DURECT (DRRX), down 29% after the FDA determined it cannot approve the New Drug Application for POSIDUR in its present form... The Medicines Co. (MDCO), down 13% after an FDA panel voted against approval for cangrelor and the company's shares were downgraded at Jefferies and at Credit Suisse.
News For TWC;CMCSA;CHTR;CSCO;MDLZ;HOT;SKX;WFM;AVP;URS;ITRI;ANGI;LF;OWW;RTRX;CRME;DRRX;MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
April 21, 2015
10:20 EDTCSCOWells thinks carrier equipment vendors factored in weak capex
Subscribe for More Information
08:23 EDTCSCOCisco results likely to beat expectations, says Bernstein
Bernstein expects Cisco to report stronger than expected results, due to strength in enterprise and commercial and continued momentum in switching, Bernstein believes that risks caused by service provider revenue was eliminated by the company's Q1 guidance, while currency fluctuations should not impact its near-term results. The firm keeps a $34 price target and Outperform rating on the shares.
08:20 EDTOWWOrbitz app now customized for Apple Watch
Subscribe for More Information
April 20, 2015
17:04 EDTCHTROn The Fly: Top stock stories for Monday
Stocks on Wall Street were higher for the day, beginning the session sharply higher and remaining in positive territory throughout. China’s central bank announced a reduction in bank reserve requirements in an effort to increase liquidity and spur economic growth within the country. Following the open, the market moved in a relatively narrow range as investors await the latest round of earnings reports for one of the season's heavier weeks. ECONOMIC EVENTS: In the U.S., the Chicago Fed National Activity Index came in at 0.42 versus expectations for positive 0.1. In Asia, the People's Bank of China lowered its reserve requirement ratio, by 1 percentage point, the lowest since the financial crisis. Despite this, the Shanghai Composite Index fell 1.6% because regulators had already begun curbing speculative trading on Friday. COMPANY NEWS: Morgan Stanley (MS) advanced 0.57%, or 21c, to $36.96 after reporting earnings prior to the market open. The bank beat on both EPS and revenue, and also raised its dividend to 15c from 10c. CEO James Gorman was pleased with the quarter and cited growth across the majority of the company's operations. MAJOR MOVERS: Among the notable gainers was Hasbro (HAS), which rose 12.55% to end the session at $74.16 after reporting EPS and revenue in excess of analyst expectations. During its earnings conference call, the company appeared confident on its 2015 offerings which include Disney (DIS) Princess and Frozen product lines. Also higher was Rovi (ROVI), gaining 8.64% to close the day at $19.11 after renewing its licensing and program guide agreement with Charter (CHTR). Among the noteworthy losers was Caesars Entertainment (CZR), tumbling 17.01% to $10 after failing to reach an agreement on its restructuring. Also lower were a number of medical companies involved in the development of CAR-T cancer therapies, including Kite Pharma (KITE), Juno Therapeutics (JUNO), blue bird bio (BLUE), and ZIOPHARM Oncology (ZIOP). The drop followed disappointing, small-scale studies presented during the annual meeting of the American Association for Cancer Research. INDEXES: The Dow rose 208.63, or 1.17%, to 18,034.93, the Nasdaq advanced 62.79, or 1.27%, to 4,994.6, and the S&P 500 gained 19.22, or 0.92%, to 2,100.4.
12:31 EDTCHTROn The Fly: Top stock stories at midday
Stocks on Wall Street were higher at midday after China’s central bank relaxed reserve requirements for its banks. The nation's own stock market struggled to overcome the cross current of other actions taken to cut down on speculative trading there, but U.S. stock markets surged at the open and had not looked back by midday. The domestic economic calendar has quiet and earnings continue to be the focal point at home, as a great number of S&P 500 companies prepare to report this week. ECONOMIC EVENTS: In the U.S., the Chicago Fed National Activity Index had a reading of -0.42, versus expectations for a +0.10 reading. A reading below zero represents economic activity below trend. In China, the People's Bank of China cut the reserve-requirement ratio, or the amount of reserves lenders need to hold, by 1 full percentage point, which was the biggest cut since the depths of the financial crisis and more than expected by economists. However, the Shanghai Composite Index still dropped 1.6%, since the reserve-requirement cut came after regulators had moved to curb speculative trading with actions taken Friday. COMPANY NEWS: Shares of Morgan Stanley (MS) advanced 1% after the bank's headline earnings excluding certain adjustments and tax benefits beat expectations. CEO James Gorman noted that the first quarter of the year was the bank's "strongest quarter in many years with improved performance across most areas of the firm." Morgan Stanley also increased its quarterly dividend to 15c per share from 10c per share. MAJOR MOVERS: Among the notable gainers was Hasbro (HAS), which gained 10% after the toymaker's sales and profits widely topped expectations in its fiscal first quarter. Also higher was Rovi (ROVI), which gained more than 10% after the company announced it has renewed its patent license and interactive program guide product agreement with Charter Communications (CHTR). Among the noteworthy losers was FARO Technologies (FARO), which dropped 25% and was downgraded by Noble Financial and Needham after the preannounced lower than expected first quarter revenue. Also lower were a number of companies that are developing CAR-T cancer therapies following the annual meeting of the American Association for Cancer Research. Mizuho analyst Peter Lawson attributed the pullback to disappointment in this weekend's solid tumor data on a small number of patients with advanced cancers who were given CAR-T therapy developed by Novartis (NVS) and the University of Pennsylvania. Shares of Kite Pharma (KITE), Juno Therapeutics (JUNO), blue bird bio (BLUE), and ZIOPHARM Oncology (ZIOP) were all lower near noon. INDEXES: Near midday, the Dow was up 236.19, or 1.32%, to 18,062.49, the Nasdaq was up 59.54, or 1.21%, to 4,991.35, and the S&P 500 was up 21.82, or 1.05%, to 2,103.00.
12:08 EDTCHTRTiming of Rovi renewal with Charter a plus, says JPMorgan
JPMorgan said the timing of the closing of Rovi's (ROVI) renewal of its IP and programming guide agreement with Charter (CHTR) is advantageous given Rovi's other impending renewals and should give some confidence that large service provider renewals don't hinge on the outcome of the company's court case with Netflix (NFLX). However, the firm added that it would not be surprised to see more volatility in Rovi shares if court rulings favor Netflix and it kept a Neutral rating on the stock.
11:10 EDTTWCStocks with call strike movement; TWC YAHOO
Subscribe for More Information
10:31 EDTANGIAngie's List announces partnership with On Deck Capital
Angie's List (ANGI) announced plans to team with On Deck Capital (ONDK) to offer financing to its service providers. As part of this agreement, service providers on Angie’s List will have access to OnDeck’s loans for up to $250,000. Qualifying service providers can use their loans to invest in their business’ growth, manage cash flow or finance their Angie’s List subscriptions.
10:29 EDTTWCOptions with increasing implied volatility: PNK PSEC TWC
Subscribe for More Information
09:52 EDTCMCSA, TWC, CHTRRovi deal with Charter a 'material' positive, says Piper Jaffray
Subscribe for More Information
08:48 EDTANGIAngie's List announces plans to team with On Deck Capital
Angie's List (ANGI) announced plans to team with OnDeck Capital (ONDK), a platform for small business loans, to offer financing to its service providers. As part of this agreement, service providers on Angie’s List will have access to OnDeck’s loans for up to $250,000. Qualifying service providers can use their loans to invest in their business’ growth, manage cash flow or finance their Angie’s List subscriptions.
08:01 EDTCHTRRovi, Charter sign multi-year license renewal
Rovi (ROVI) announced that the company has renewed its patent license and interactive program guide product agreement with Charter Communications (CHTR). The license renewal extends Charter’s IPG patent license. Under the terms of the agreement, Charter will also be able to license Rovi’s products and services, including Rovi Search, Recommendations and Conversation Services, Rovi Metadata and Rovi Analytics.
07:56 EDTCHTR, CMCSA, TWCCharter would pursue Time Warner if Comcast deal blocked, says UBS
Subscribe for More Information
07:07 EDTMDCOThe Medicines Co. reports FDA approves new formulation of MINOCIN
Subscribe for More Information
07:02 EDTMDCOEagle Pharmaceuticals price target raised to $75 from $55 at Piper Jaffray
Subscribe for More Information
06:39 EDTTWC, CMCSADOJ lawyers leaning towards recommending block of Comcast deal, NY Times says
The Justice Department's staff lawyers are leaning towards recommending that Comcast's (CMCSA) takeover of Time Warner Cable (TWC) be blocked, according to The New York Times, which cited an unnamed source. Reference Link
05:55 EDTCMCSAStocks with implied volatility movement; RSX CMCSA
Stocks with implied volatility movement; Market Vectors Russia ETF (RSX) 40, Comcast (CMCSA) 25 according to iVolatility.
05:47 EDTTWCStocks with implied volatility movement; TWC CSX
Subscribe for More Information
April 19, 2015
15:24 EDTCMCSAComcast's 'Furious 7' leads U.S. weekend box office with $29.1M
For the weekend of April 19, Universal's (CMCSA, CMCSK) "Furious 7" topped domestic box office charts at $29.1M. Sony's (SNE) "Paul Blart: Mall Cop 2" landed in second place with $24M for the weekend while Universal's "Unfriended" came in third with $16M. Fox's (FOX, FOXA) "Home" and "The Longest Ride" took fourth and fifth place at $10.3M and $6.8M, respectively. Data gathered by Rentrak.
12:23 EDTCMCSA, TWCTime Warner Cable, Comcast set to meet with DoJ, WSJ says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use